Wait times for diagnosis exceed accepted targets Adjuvant therapy has feverish results in real-world careFebrile neutropenia observed at higher than expected rate Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist Groups collaborate on chronic disease prevention $15.5M invested in chronic disease prevention by Canadian Partnership Against Cancer Nova Scotia, Newfoundland form breast cancer screening partnership Surviving cancer poses heart disease risk Breast imaging technique may cut unneeded biopsies Hospital report cards may save lives Ont. study gets a negative slant in JAMA, but lead researcher is upbeat about results Shorter radiotherapy trumpeted for high-risk prostate cancer First Previous 68 69 70 71 72 Next Last
